Investigating how mutations affect kidney protein folding and function
Single-molecule Measurements of Membrane-protein Folding and Ligand-Interaction Energetics in Bacteriorhodopsin and the Diabetes-insipidus-involved Vasopressin Receptor 2
This study is looking at a protein that helps control how much urine your kidneys make, and it’s trying to find out how changes in this protein can lead to nephrogenic diabetes insipidus, with the hope of discovering new treatments that could help people with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Clemson University NIH-funded |
| Lab location | 1 site (Clemson, United States) |
| Project ID | NIH-10907840 on NIH RePORTER |
What this research studies
This research focuses on the human arginine vasopressin receptor 2 (AVPR2), a protein crucial for regulating urine volume in the kidneys. It aims to understand how mutations in this protein lead to nephrogenic diabetes insipidus (NDI) by causing misfolding. The study employs advanced techniques to measure the stability of the protein in its folded and misfolded states, particularly in the presence of specific drugs that may help stabilize its function. By gaining insights into the molecular dynamics of AVPR2, the research seeks to inform potential therapeutic strategies for patients with NDI.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with nephrogenic diabetes insipidus, particularly those with mutations in the AVPR2 gene.
Not a fit: Patients without mutations in the AVPR2 gene or those with other forms of diabetes insipidus may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for nephrogenic diabetes insipidus, enhancing kidney function and quality of life for affected patients.
How similar studies have performed: While the approach to studying AVPR2 is innovative, similar research on G-protein coupled receptors has shown promise in understanding protein dynamics and therapeutic interventions.
Where this research is happening
Clemson, United States
- Clemson University — Clemson, United States (Active)
Researchers
- Principal investigator: Jacobson, David R — Clemson University
- Study coordinator: Jacobson, David R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.